On the eve of BIO 2009, DSM has announced that its proprietary XD Technology can boost bioreactor productivity and titers of mammalian cell culture processes by 5-10 fold for the production of proteins and antibodies. The company said that recent studies completed at the R&D labs of DSM Biologics in Groningen, The Netherlands, demonstrated that the yields from CHO-based cell cultures “can be increased 5-10 fold over previous fed-batch processes using only off the shelf, commercially av...